Feed - News and features

• Datroway joins Trodelvy for frontline TNBC in the EU
  AstraZeneca and Daiichi Sankyo's...
• Apnimed IPO raises $192m, as three other biotechs set terms
  Sleep apnoea drug developer Apnimed...
• Adcomm backs Replimune melanoma drug, despite data concern
  Replimune's RP1 immunotherapy for...
• Pfizer cues up vitiligo filing for Litfulo after phase 3 win
  Pfizer's JAK inhibitor Litfulo hits...

News | PharmaTimes

• Vista trial begins dosing in precision cancer vaccine study
• Lynavoy recommended for EU approval by the CHMP
• Atsena gains EMA orphan status for two gene therapies
• J&J reports major survival gains with dual‑target myeloma regimen
• OrbusNeich begins Japanese trial for drug‑coated balloon

• Paclitaxel Oral Solution in HER2-Positive Breast Cancer Neoadjuvant Therapy: A Dose-Finding Study
• Effects of Various Types of Ultrasound Therapy in Knee Osteoarthritis
• Terbinafine for CSA-AKI Prevention
• Elemene Liposomes in Endometrial Cancer